Home › Cancro colorettale › Illinois › Arlington Heights
Studi clinici su Cancro colorettale a Arlington Heights, IL
12 studi su Cancro colorettale cercano partecipanti presso sedi a Arlington Heights e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Family Communications After Genetic Testing
In reclutamentoVolontari sani benvenuti
- Advocate Good Shepherd Hospital, Barrington · a 9 mi di distanza
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Advocate Good Shepherd Hospital, Barrington · a 9 mi di distanza
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
In reclutamentoFase 3
- Illinois Cancer Specialists, Arlington Heights
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
In reclutamentoFase 3
- Illinois Cancer Specialists, Arlington Heights
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
In reclutamentoFase 3
- Illinois Cancer Specialists, Arlington Heights
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
In reclutamentoFase 3
- Alexian Brothers Medical Center, Elk Grove Village · a 6 mi di distanza
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
In reclutamentoFase 1
- Illinois Cancer Specialists, Arlington Heights
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
In reclutamentoFase 3
- Illinois Cancer Specialists, Arlington Heights
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
In reclutamentoFase 2
- Illinois Cancer Specialists, Arlington Heights
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
In reclutamentoStudio osservazionale
- Advocate Good Shepherd Hospital, Barrington · a 9 mi di distanza
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
In reclutamentoStudio osservazionale
- Advocate Good Shepherd Hospital, Barrington · a 9 mi di distanza
Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Gastroenterology and Internal Medicine Specialists, Lake Barrington · a 12 mi di distanza
Studi su Cancro colorettale in altre città
- Houston, TX102 studi
- New York City, NY78 studi
- Nashville, TN69 studi
- Boston, MA63 studi
- Los Angeles, CA59 studi
- Arlington, VA52 studi
- St. Louis, MO50 studi
- San Antonio, TX46 studi
- Philadelphia, PA44 studi
- Grand Rapids, MI40 studi
- Baldwin Park, CA37 studi
- Chicago, IL34 studi
Altri studi a Arlington Heights
- Cancro del polmone non a piccole cellule12 studi
- Cancro ai polmoni9 studi
- Cancro al seno7 studi
- Insufficienza cardiaca7 studi
- Cancro metastatico6 studi
- Colite ulcerosa6 studi
- Cancro del colon6 studi
- Cancro ovarico5 studi
- Obesità5 studi
- Sovrappeso5 studi
- Cancro alla prostata3 studi
- Disturbi della pelle3 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.